Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The role of the pharmacist in optimizing the use of erythropoietin stimulating agents
2
Zitationen
2
Autoren
2009
Jahr
Abstract
To minimize or prevent the complications associated with ESAs use, cancer patients should be adequately monitored and counseled. This highlights the importance of the pharmacist's involvement to optimize patient care.
Ähnliche Arbeiten
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
1996 · 22.101 Zit.
Anemia of Chronic Disease
2005 · 3.705 Zit.
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 · 2.734 Zit.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 · 2.172 Zit.
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 · 2.089 Zit.